Himalaya Nutravedics India IPO: Price Band, Lot Size, Financials & Review
Himalaya Nutravedics India IPO listed on BSE on Tue, 29 Sep 2026. The issue was subscribed 2.41x overall.
- Open Date
- 22 Sep 2026
- Close Date
- 24 Sep 2026
Last updated
- Price band
- ₹100 – ₹106
- Lot size
- 1,200 shares
- Min. investment
- ₹2,54,400
- Issue size
- ₹26.5 Cr
- Last GMP
- 0
- Subscribed
- 🔥 2.41x
Himalaya Nutravedics India IPO details
Himalaya Nutravedics India IPO is a ₹26.5 Cr book-building IPO on the SME segment, listing on BSE. It is entirely a fresh issue of shares, so all the money raised goes to the company; there is no offer for sale by existing shareholders.
The issue was open from Tue, 22 Sep 2026 to Thu, 24 Sep 2026. Allotment was finalised on Fri, 25 Sep 2026, and the shares listed on BSE on Tue, 29 Sep 2026.
The price band is ₹100 to ₹106 per share and the lot size is 1200 shares, so the minimum retail application is ₹2,54,400. Retail investors can apply for up to 2 lots (2,400 shares, ₹2,54,400).
KFin Technologies Limited is the registrar, and Nirbhay Capital Services Private Limited is the book running lead manager.
Grey market premium (GMP)
Day-wise GMP →The last Himalaya Nutravedics India IPO GMP before listing was 0 (0.00% against the upper price band of ₹106), implying an estimated listing price of ₹106. Across 10 days of tracking, GMP ranged from 0 (20 Sep) to 0 (20 Sep).
| Last GMP | 0 |
|---|---|
| GMP vs upper band | 0.00% |
| Estimated listing price | ₹106 |
| Highest (20 Sep) | 0 |
| Lowest (20 Sep) | 0 |
Grey market trading is unofficial and unregulated. GMP is a sentiment indicator, not a guarantee of the listing price. See the Himalaya Nutravedics India IPO day-wise GMP.
Subscription
Day-wise subscription →Himalaya Nutravedics India IPO was subscribed 2.41x overall: QIB 1.00x, NII 3.93x and retail 2.56x.
| Category | Subscribed |
|---|---|
| QIB | 1.00x |
| NII | 3.93x |
| └ bNII (above ₹10 lakh) | 4.37x |
| └ sNII (₹2–10 lakh) | 3.04x |
| Retail | 2.56x |
| Total | 2.41x |
Final figures at the close of bidding on 24 Sep 2026. Category-wise bids, application-wise breakup and allotment chances are on the Himalaya Nutravedics India IPO day-wise and category-wise subscription page.
Share reservation by category
| Category | Shares offered | Share of issue |
|---|---|---|
| Anchor Investors | 7,10,400 | 29.93% |
| Qualified Institutions | 4,74,000 | 19.97% |
| Non-Institutional | 3,56,400 | 15.02% |
| └ BNII | 2,37,600 | 10.01% |
| └ SNII | 1,18,800 | 5.01% |
| Retail Investors | 8,32,800 | 35.09% |
| Total | 23,73,600 | 100.00% |
Shares offered include the anchor investor portion, which is allotted a day before the issue opens. Subscription figures exclude anchors, so category sizes on the subscription page are smaller.
Himalaya Nutravedics India IPO lot size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,54,400 |
| Retail (Max) | 2 | 2,400 | ₹2,54,400 |
| S-HNI (Min) | 3 | 3,600 | ₹3,81,600 |
| S-HNI (Max) | 7 | 8,400 | ₹8,90,400 |
| B-HNI (Min) | 8 | 9,600 | ₹10,17,600 |
Amounts at the upper end of the price band.
Issue structure and valuation
It is entirely a fresh issue of shares, so all the money raised goes to the company; there is no offer for sale by existing shareholders.
At the upper price band of ₹106, the issue is priced at 9.04x pre-issue earnings and 12.63x post-issue earnings per share.
The post-issue P/E is higher because the fresh issue adds new shares, which spreads the same profit over more shares.
Listed peers with positive earnings trade at a median P/E of 23.69x (2 companies).
Promoter holding falls from 95.14% before the issue to 69.94% after it.
| EPS (pre-issue) Latest earnings per share before the issue | ₹11.72 |
|---|---|
| P/E (pre-issue) Upper price band ÷ pre-issue EPS | 9.04x |
| EPS (post-issue) EPS on the enlarged share capital | ₹8.39 |
| P/E (post-issue) Upper price band ÷ post-issue EPS | 12.63x |
| Promoter holding (pre-issue) | 95.14% |
| Promoter holding (post-issue) | 69.94% |
Himalaya Nutravedics India Limited financials
Between 31 Mar 2025 and 31 Mar 2026, Income rose from ₹21 Cr to ₹43.12 Cr, and profit after tax rose from ₹2.23 Cr to ₹7.39 Cr. The PAT margin for 31 Mar 2026 was 17.14%.
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 24.42 | 10.82 | 6.09 |
| Total Income | 43.12 | 21.00 | 14.43 |
| Profit After Tax | 7.39 | 2.23 | 0.43 |
| EBITDA | 8.10 | 2.99 | 0.94 |
| Net Worth | 16.38 | 6.75 | 1.34 |
| Reserve & Surplus | 10.07 | 2.76 | 0.53 |
| Total Borrowings | 5.13 | 1.76 | 3.24 |
₹ in crore, as stated in the prospectus.
Key performance indicators
| KPI | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| ROE % | 63.87 | 55.02 | 37.29 |
| ROCE % | 36.41 | 30.18 | 17.00 |
| Debt / Equity | 0.31 | 0.26 | 2.39 |
| RoNW % | 45.12 | 33.08 | 31.77 |
| Pat Margin % | 17.16 | 10.63 | 2.95 |
Peer comparison
| Company | Face value | P/E | EPS (basic) | EPS (diluted) | RoNW | NAV |
|---|---|---|---|---|---|---|
| Himalaya Nutravedics India Ltd | 10 | — | 12.05 | 12.05 | 45.12% | 26.70 |
| Jeena Sikho Lifecare Ltd | 2 | 26.75 | 17.84 | 17.81 | 27.67% | 37.60 |
| Sandu Pharmaceuticals Ltd | 10 | 20.62 | 1.83 | 1.83 | 2.53% | 45.21 |
From the prospectus. P/E is shown as — when earnings are zero or negative, or not reported for the issuer before listing.
Objectives
The company intends to allocate the net proceeds from the offering to the following objectives.
| Sr | Objective |
|---|---|
| 1 | Funding Working Capital Requirements |
| 2 | Business Development and Digital Marketing Activities |
| 3 | General Corporate Purposes |
About Himalaya Nutravedics India Limited
Himalaya Nutravedics India Limited, incorporated in June 2022, is a Hyderabad-based manufacturer of Ayurvedic and nutraceutical products. The company is engaged in the formulation, manufacturing, and marketing of a diverse range of products, including Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders. Its product portfolio caters to various therapeutic and wellness categories, including digestive health, immunity, metabolic health, and pain management.
The company markets its branded products through healthcare practitioners and also provides third-party contract manufacturing services. Since its inception, it has expanded its distribution and market presence across 17 states and one Union Territory in India.
Himalaya Nutravedics India Limited operates a manufacturing facility in Hyderabad, Telangana, which is certified under ISO 22000:2018, ISO 9001:2015, and WHO-GMP standards, reflecting its focus on quality, food safety, and good manufacturing practices.
As of April 30, 2026, the company had a total workforce of 80 employees.
Promoters
- Rohit Asawa
- Divya Asawa
- Chanda Asawa
- Rama Raju Penmatsa
Contact details
Himalaya Nutravedics India Ltd.
Plot No. 101/A, Phase-III,
Industrial Development Park,
Cherlapally, Hindustan Cables Ltd, Uppal
Hyderabad, Telangana, 500051
Tel. No.: 040-79615565
E-mail: himalaya.ipo@kfintech.com
Website: https://www.himalayanutravedics.com/
Himalaya Nutravedics India IPO FAQs
- What is the Himalaya Nutravedics India IPO price band?
- The Himalaya Nutravedics India IPO price band is ₹100 to ₹106 per share.
- What is the Himalaya Nutravedics India IPO lot size and minimum investment?
- The Himalaya Nutravedics India IPO lot size is 1200 shares. The minimum retail investment is ₹2,54,400 for one lot at the upper price band. Retail investors can apply for up to 2 lots (2,400 shares), costing ₹2,54,400.
- When was Himalaya Nutravedics India IPO open for subscription?
- Himalaya Nutravedics India IPO was open for subscription from Tue, 22 Sep 2026 to Thu, 24 Sep 2026.
- What is the Himalaya Nutravedics India IPO subscription status?
- Himalaya Nutravedics India IPO was subscribed 2.41x overall: QIB 1.00x, NII 3.93x and retail 2.56x. Day-wise and category-wise figures are on the subscription page.
- What was the Himalaya Nutravedics India IPO GMP before listing?
- The last Himalaya Nutravedics India IPO GMP before listing was 0 (0.00% against the upper price band of ₹106), implying an estimated listing price of ₹106. Across 10 days of tracking, GMP ranged from 0 (20 Sep) to 0 (20 Sep). GMP is an unofficial grey market indicator and can change quickly.
- What is the Himalaya Nutravedics India IPO allotment date?
- The Himalaya Nutravedics India IPO basis of allotment was finalised on Fri, 25 Sep 2026. You can check your allotment status on the KFin Technologies Limited website.
- What is the Himalaya Nutravedics India IPO listing date?
- Himalaya Nutravedics India IPO listed on BSE on Tue, 29 Sep 2026.
- Is the Himalaya Nutravedics India IPO a fresh issue or an offer for sale?
- It is entirely a fresh issue of shares, so all the money raised goes to the company; there is no offer for sale by existing shareholders.
- Who are the registrar and lead managers of the Himalaya Nutravedics India IPO?
- The registrar for the Himalaya Nutravedics India IPO is KFin Technologies Limited, and the book running lead manager is Nirbhay Capital Services Private Limited.
Data is compiled from the prospectus, stock exchanges and market sources and is for information only. It is not investment advice; read the RHP before applying.